Chapter 142 Press Conference (Part 1)
Li Qingye stayed in the Black Tiger Canyon for more than a week, then disguised himself as another person and went directly to Bhinmar.
As the capital of Hongsavadi, Bianmana is currently developing well.
Originally, there was no direct connection between Kayah State and Byinmana District by road, rail or water.
However, during the massive infrastructure construction wave at the end of last year, Qingye Group built two expressways between the two places .
Currently, Li Qingye’s convoy is on the highway from Loikaw, the capital of Kayah State, to Byinmana. In fact, the distance between the two cities is very close, with a straight-line distance of only about 105 kilometers.
This expressway directly crosses the Bennong Mountain Range, reducing the original detour distance of about 300 kilometers to 127 kilometers.
The convoy arrived in Bhinmar in less than two hours.
Sitting in a specially made minibus, Li Qingye looked at the prosperous scene outside the window and said, "It seems that this place has become much more prosperous."
As a guide specially sent by the Hongsavadi branch, Mao Siqiang whispered back: "All this is supported by the company."
"I heard there's a new drug launch today?"
"Yes, over there in Emerald Plaza."
"Go and have a look."
The convoy soon arrived near Emerald Plaza, but did not drive directly there. Instead, it first stopped at the Emerald Hotel.
After changing to a small SUV, he headed to Jade Plaza in a low-key manner.
Entering Jade Plaza, there are quite a lot of people here, but many people are wearing masks. Although the new test paper can keep many infectious diseases out of the country, many people still choose to wear masks.
This square is very large, with 40,000 square meters of open space alone. Surrounding it are the headquarters of Aoba Medical Company, Aoba Hospital, Aoba Bank, Hongsavadi Mining Company, Hongsavadi Investment Foundation, Hongsavadi Chamber of Commerce and other institutions.
Maung Siqiang introduced to him: "Due to the geographical restrictions, the future development of Bianmana will focus on financial services, medical and health care, and transportation hubs."
"Let's go!"
Entering the headquarters building of Qingye Medical, it is a standard 20-story building, but the area it covers is not very large.
Through a special passage at the back door, the group entered a small box on the third floor.
Through the single-sided glass window of the small box, you can see the press conference hall on the second floor.
At this time, there were about two thousand practitioners and news media in the conference hall below who came to participate in the conference.
Li Qingye flipped through the list of participating companies on the internal document and found something interesting: "Have European pharmaceutical companies such as Sanofi, Novartis, Roche, and Bayer all come?"
"Johnson & Johnson wanted to come through the channel of its Chinese branch, but later canceled the plan." Philip explained in a low voice.
"Forget it, they are competitors after all." Li Qingye was not surprised.
Sapiens has a very cold attitude towards these European and American pharmaceutical companies, and the two sides have very little cooperative business.
Especially recently, Qingye Medical has earned tens of billions of dollars in materials from the sales of rapid test strips around the world, which has made European and American pharmaceutical companies envious and jealous of the Qingye Group.
Many regions and enterprises were forced to recognize the value of the gold and yuan, and even developed specialized re-export trade.
For example, Siam's Charoen Pokphand Company recently purchased a large number of special-effect drugs and test strips from Aoba Group through re-export, and then sold them to other regions and companies, while helping Aoba Group purchase designated materials and equipment.
By earning the difference between the two prices, they made hundreds of millions of dollars.
However, Zhengda Company is not without competitors. For example, Zhiren Company is also openly reselling test strips and special medicines.
This time at the new drug launch conference.
Xie Bin from Zhengda Company and Harry from Zhiren Company both came to participate in person.
The press conference officially began at around 3:30 in the afternoon.
The person in charge of the press conference on the stage was Tian Hemeng, vice president of Qingye Medical Company. After she said some polite words, she went straight to the point.
"Our company has been committed to developing drugs to fight diseases. Recently, a scientific research team led by our chairman and technical executive, Mr. Li Qingye, has successfully developed two new viral antibiotics through whole genome sequencing and supercomputer simulation calculations..."
Martin, general manager of Roche Southeast Asia branch, felt a little surprised. Is it another new type of viral antibiotic?
Viral antibiotics are a new term currently being discussed in the global medical community, mainly referring to special antibiotics such as "Aiqingling" and "Rabies Killer".
As the developer of this type of antibiotics, Li Qingye established his position in the medical field with this technology and is known as the "Father of Viral Antibiotics."
Of course, the flattery of the Western academic community is not entirely well-intentioned, but rather contains more greed and malice.
For example, assassinations in the name of academic exchanges, or technology theft, and even some medical scientists with ulterior motives shouted the slogan "This technology belongs to all mankind."
Li Qingye sneered at these so-called flattery. He would not be a fool.
When they were studying at Jiangcheng University, several angry mentors taught them some painful lessons of the last century.
For example, the new penicillin culture medium technology and cheap vitamin synthesis technology developed by Chinese scientists were directly "borrowed" for free by European and American pharmaceutical companies because they did not pay attention to confidentiality and patents.
Li Qingye certainly understands the nature of Westerners. When someone flatters you, there is a high probability that he or she is plotting something bad.
For example, at this time, the Western medical community was still blowing the Nobel Prize wind, as if as long as Li Qingye made the technical principles public, the Nobel Prize would be within his grasp.
Indeed, if Li Qingye was willing to disclose the principles of his technology, the West would definitely not be stingy with a medal, and would even erect a statue of him "healing the world".
But the question is, is Li Qingye the kind of fool who would be fooled?
After he suffered a series of misfortunes, his personality has become extremely selfish. Coupled with the existence of a large amount of ancestral memories, Li Qingye has become extremely rational, even to the point of being a little cold and ruthless.
Even if the Western medical community praises him to the sky, he will not be grateful, but will only think that these guys are plotting something bad.
…
Just as Martin of Roche was thinking secretly.
People from other companies are also speculating what Qingye Medical's new drug will be.
Among them, Xie Bin from Zhengda Company was the most enthusiastic. After all, their company made a lot of money through re-export.
As for Harry from Sapiens, he looked calm and composed. As a high-level Spider Web manager , Harry understood the secret relationship between Aoba Group and Sapiens, and naturally knew what the new drug launched at this press conference was.
Tian Hemeng did not keep anyone in suspense and directly announced the first new drug:
"This is an antibiotic developed based on the genetic target of Ebola, specifically for Ebola - Anti-Toxin No. 3 , a special medicine. Its therapeutic effect is similar to Anti-Toxin No. 1 - Ai Qing Ling and Anti-Toxin No. 2 - Rabies Killer."
Ebola? Everyone looked at each other in bewilderment, or perhaps a little disappointment.
Although Ebola is incredibly lethal, it is very contagious and usually only occurs on a small scale in Africa.
Obviously this is a niche drug, similar to Rabies Killer for treating rabies, and the market is very small.
Moreover, considering the economic situation in Africa, there are probably not many patients who can afford the special anti-drug drug No. 3.
Of course, some charities, or the World Health Organization, the Red Cross, etc., may purchase some to go to Africa to win people's hearts.
Tian Hemeng was not surprised by the reactions of the people present, but she still introduced the price. As expected, the price was very high, with the retail price of one box reaching 10,000 gold yuan.
"Next I will announce the second new drug..."
